Cannvas MedTech (CSE:MTEC)(Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce that Cannvas.Me, its first cannabis-centric service offering to the public, will go live on October 4, 2018. Cannvas.Me is a scalable and comprehensive solution for the global cannabis community offering interactive tools and physician-backed content to all audiences wishing to learn about health care through cannabis.

“With the legalization of cannabis in Canada quickly approaching, Cannvas.Me fills the information void with a wide range of credible information on the potential benefits of cannabis,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “Our solution is to have information available to customers where and when they need it. It could be on a tablet in a medical clinic or doctor’s office, at home on a desktop, or anywhere on a mobile device. Cannvas.Me is there to provide valuable physician-backed information and content, and because we are not affiliated with any of the large cannabis producers we can assure customers our information is truly unbiased.”

Cannvas has been systematic in its approach to the development of the innovative platform, ensuring a best-in-class experience for all users. The free platform utilizes machine-learning algorithms and artificial intelligence (AI) to contextualize and adapt to its users. Content will be served in a geographic and personal manner relevant to the customer.  The contextual AI-supported service also ensures each customer’s journey is built upon their last interaction, giving individuals a uniquely progressive experience.

Cannvas.Me features an innovative set of tools making cannabis education approachable and accessible to a global audience, including:

  • educational learning modules created by medical practitioners and certified educators as part of its Cannvas Academy;
  • an interactive Cannvas Strain Matcher teaching users which strains best alleviate specific ailments;
  • curated recipes and culinary cannabis training with Cannvas Culinary;
  • and more.

The physician-backed information presented on the site is vetted through a series of systems and reviews to ensure the most accurate and up-to-date information is available.  Cannvas has formed three advisory boards and panels with seasoned medical and educational professionals who are at the forefront of their respective fields:

  • Health and Innovation Advisory Board
  • Medical Advisory Board
  • Education Advisory Panel

The members of the advisory boards work with the senior executive team to create original content for the platform offering users relevant and credible information in a rich and contextual environment.

“A lot of hard work and effort has gone into the first phase of Cannvas.Me and we welcome everyone to come and explore the platform on October 4, 2018,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “We are working with a growing list of partners to expand our business and welcome new customers from all walks of life. Additional features will be added in weekly updates of Cannvas.Me and while we are focused on Canadafor our launch, we look forward to expanding our offering to global markets in the future.”

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted

For further information:; Media Inquiries:; Investor Relations,, 1-800-489-0116


Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less